FindTrial
Sign In

Tolerance and immunological response in HIV seropositive individuals after NR100063 supplementation

Tolerance and immunological response in HIV seropositive individuals after NR100063 supplementation

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-000567-25-IT
Enrollment
Unknown
Registered
2005-09-02
Start date
2005-08-10
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV infection MedDRA version: 6.1 Level: SOC Classification code 10021881

Interventions

Product Code: 100063 Pharmaceutical Form: Powder for oral solution Current Sponsor code: 100063 Concentration unit: g gram(s) Concentration type: equal Concentration number: 16- Product Code: 100063

Sponsors

NUMICO RESEARCH BV
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Secondary Objective: ;Primary end point(s): ;Main Objective:—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026